Robin Feldman on Drug Patents, Generics, and Drug Wars

EconTalk

Library of Economics and Liberty

Ethics, Philosophy, Economics, Books, Science, Business, Courses, Social Sciences, Society & Culture, Interviews, Education, History

4.7 • 4.3K Ratings

🗓️ 26 June 2017

⏱️ 65 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Robin Feldman of the University of California Hastings College of Law and author of Drug Wars talks about her book with EconTalk host Russ Roberts. Feldman explores the various ways that pharmaceutical companies try to reduce competition from generic drugs. The conversation includes a discussion of the Hatch-Waxman Act and the sometimes crazy world of patent protection.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Econ Talk, part of the Library of Economics and Liberty.
0:08.5	I'm your host, Russ Roberts of Stanford University's Hoover Institution.
0:13.1	Our website is econtalk.org, where you can subscribe, comment on this podcast, and find
0:18.1	links and other information related to today's conversation.
0:21.0	You'll also find our archives where you can listen to every episode we've ever done going
0:25.3	back to 2006.
0:27.5	Our email address is mailadycontalk.org.
0:30.0	We'd love to hear from you.
0:31.5	Today is June 6, 2017.
0:36.4	My guest is Robin Feldman, the Harry and Lillian Hastings Professor of Law and Director
0:42.4	of the Institute for Innovation Law at the University of California Hastings College
0:46.8	of the Law.
0:47.8	She has written widely on intellectual property, her latest book, which is the topic of today's
0:52.6	discussion is Drug Wars, how Big Farmer raises prices and keeps generics off the market
0:58.3	Robin Welcomedy-Contalk.
0:59.3	Nice to be here.
1:01.5	Before I read your book, I thought I understood patents and generics.
1:08.3	I was a happier person too.
1:11.0	But after I read your book, let me give you the before.
1:13.1	I would have said, well, it's kind of straightforward.
1:16.0	A drug company discovers an interesting drug.
1:21.2	They get FDA approval and patent it.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Library of Economics and Liberty, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Library of Economics and Liberty and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.